Arvinas, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ARVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
395 Winchester Ave, 5 Science Park, New Haven, Connecticut

Insiders trading volume in the past year

Arvinas, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John G. Houston President and CEO, Director $51.7 M -$244 K -0.47% Feb 23, 2024
Sean A. Cassidy Chief Financial Officer $8.56 M -$80.1 K -0.93% Feb 23, 2024
Ian Taylor Chief Scientific Officer $7.87 M -$80 K -1.01% Feb 23, 2024
Noah Berkowitz Chief Medical Officer $4.49 M Mar 18, 2024
Andrew Saik Chief Financial Officer $4.4 M Jun 24, 2024
Ronald Peck Chief Medical Officer $4.11 M -$112 K -2.66% Feb 23, 2024
Randy Teel Int. Chief Financial Officer $3.11 M May 21, 2024
Angela M. Cacace Chief Scientific Officer $2.83 M Jun 17, 2024
Edward Moore Kennedy Jr. Director $2.63 M May 29, 2024
Briggs Morrison Director $1.56 M May 29, 2024
Sunil Agarwal Director $810 K May 29, 2024
Everett Cunningham Director $617 K May 29, 2024
Linda Bain Director $617 K May 29, 2024
Leslie Norwalk Director $617 K May 29, 2024
Laurie Smaldone Director $617 K May 29, 2024
John Young Director $617 K May 29, 2024
Wendy L. Dixon Director $351 K Jun 15, 2023
David K. Loomis Chief Accounting Officer $276 K Feb 23, 2024
Timothy M. Shannon Director $163 K Jun 16, 2022
Liam Ratcliffe Director $163 K Jun 16, 2022
Bradley Margus Director $163 K Jun 16, 2022

Recent Insider Transactions by Companies or Individuals for Arvinas, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership